Evidence map›Paper›PMID 38580879›Full record

ArticleEMBO reports2024

Harmful uses of patentable neurotechnology: a new regulatory approach : Proposing a framework safeguarding human rights and social responsibility for patented applications of neuroscience.

R Roland Nadler, Tade M Spranger, Ari Rotenberg, Tanya A Barretto, Julia Hansmann, Anna Hemmer, Zelma Ht Kiss, John Dw Madden, Michael J Strong, Judy Illes

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EMBO reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

R Roland NadlerPeter A. Allard School of Law, University of British Columbia, Vancouver, Canada. nadler@student.ubc.ca.ORCID 0000-0002-9504-7527
Tade M SprangerCentre for the Law of Life Sciences, Rechts- und Staatswissenschaftliche Fakultät, Universität Bonn, Bonn, Germany. tadespranger@web.de.ORCID 0000-0003-1256-9379
Ari RotenbergNeuroethics Canada, Division of Neurology, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
Tanya A Barretto *Neuroethics Canada, Division of Neurology, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
Julia Hansmann *Centre for the Law of Life Sciences, Rechts- und Staatswissenschaftliche Fakultät, Universität Bonn, Bonn, Germany.
Anna Hemmer *Centre for the Law of Life Sciences, Rechts- und Staatswissenschaftliche Fakultät, Universität Bonn, Bonn, Germany.
Zelma Ht Kiss *Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Canada.
John Dw Madden *Department of Electrical and Computer Engineering, University of British Columbia, Vancouver, Canada.
Michael J Strong *Department of Clinical Neurological Sciences, Schulich School of Medicine & Dentistry, Western University, London, Canada.
Judy IllesNeuroethics Canada, Division of Neurology, Faculty of Medicine, University of British Columbia, Vancouver, Canada.

Funding

Canadian Government | CIHR | Institute of Neurosciences, Mental Health and Addiction (INMHA) #ERN-174185
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Human RightsNeurosciencesPatents as TopicSocial ResponsibilityHumans

Identifiers

PMID38580879
PMCPMC11094056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.